HK1237803B - 鞭毛蛋白组合物及用途 - Google Patents

鞭毛蛋白组合物及用途 Download PDF

Info

Publication number
HK1237803B
HK1237803B HK17112073.6A HK17112073A HK1237803B HK 1237803 B HK1237803 B HK 1237803B HK 17112073 A HK17112073 A HK 17112073A HK 1237803 B HK1237803 B HK 1237803B
Authority
HK
Hong Kong
Prior art keywords
artificial sequence
flagellin
dna
sequence
composition
Prior art date
Application number
HK17112073.6A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1237803A1 (zh
Inventor
Mett Vadim
Original Assignee
Genome Protection, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genome Protection, Inc. filed Critical Genome Protection, Inc.
Publication of HK1237803A1 publication Critical patent/HK1237803A1/zh
Publication of HK1237803B publication Critical patent/HK1237803B/zh

Links

HK17112073.6A 2014-07-30 2015-07-29 鞭毛蛋白组合物及用途 HK1237803B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462031116P 2014-07-30
US201562110744P 2015-02-02
US201562117366P 2015-02-17

Publications (2)

Publication Number Publication Date
HK1237803A1 HK1237803A1 (zh) 2018-04-20
HK1237803B true HK1237803B (zh) 2021-03-05

Family

ID=

Similar Documents

Publication Publication Date Title
US11034733B2 (en) Flagellin compositions and uses
US10196435B2 (en) OX40L fusion protein for the immunotherapy of tumors of veterinary animals
US20220024991A1 (en) Engineered flagellin-derived compositions and uses
JP2021530444A (ja) 固形および液体悪性病変における多重ｃａｒ ｔ細胞での複数抗原の標的化
WO2016014899A1 (en) Flagellin derivatives and uses
EP4281116A1 (en) Bone-specific delivery of polypeptides
CN116615248A (zh) 抗体-药物缀合物和cdk9抑制剂的组合
US20220185857A1 (en) Fms-like tyrosine kinase 3 ligand (flt3l)-based chimeric proteins
HK1237803B (zh) 鞭毛蛋白组合物及用途
HK1237803A1 (zh) 鞭毛蛋白组合物及用途
CA3167799C (en) Combined use of pertuzumab, trastuzumab, and anthracycline-based chemotherapy for neoadjuvant therapy of early-stage her2-positive breast cancer
EP4351618A2 (en) Trem-2/dap-12 inhibitors for treating lung disease and injury and combinations thereof
EP4600270A1 (en) Anti-cd7 single domain antibody (sdab), a pharmaceutical composition and a kit for use in the diagnosis and/or therapy of cancer
AU2024280595A1 (en) Anti-cd2 single domain antibody, a pharmaceutical composition and a kit for use in the diagnosis and/or therapy of cancer
WO2016073733A1 (en) Methods of treating cancer using lipopeptides
Cao et al. Effects of Oncostatin M on the neurological function of rats with spinal cord injury through STAT3 signal pathway
Khranovska et al. 4116 Fusion genes PAX3/7-FKHR as molecular markers of bone marrow micrometastasis in paediatric alveolar rhabdomyosarcoma